- Breast Cancer
- Cancer Control
- Chemotherapy
- Diagnostics and Screening
- Gastrointestinal Cancers
- Genitourinary Cancers
- Geriatric Oncology
- Gynecological Oncology
- Head, Neck and Thyroid Cancers
- Hematology
- Hematological Malignancies
- Imaging
- Lung Cancer
- Neurological Cancers
- Pediatric Oncology
- Radiotherapy
- Sarcomas and Melanomas
- Supportive Oncology
Specialties
Fri, 2012-06-01
Thu, 2012-06-14
Thu, 2012-06-28
Latest Testimonial
"Very well done and exciting. Congratulations."
Professor of Medicine and Director
Emili Montserrat
Institute of Hematology and Oncology at the Hospital Clinic of Barcelona
Head, Neck and Thyroid Cancers
- Metastatic Head and Neck Cancer
- Medullary Treatment
- Targeted Chemotherapy
- Medullary or Anaplastic Thyroid Cancer
Metastatic Head and Neck Cancer
Targeted Therapy in Combination with Chemotherapy in Recurrent and/or Metastatic Head and Neck Cancer
Pol Specenier, Jan B Vermorken
European Oncology, 2010;6(1):43-6
Medullary Treatment
Advances in the Prognosis and Treatment of Medullary or Anaplastic Thyroid Cancer
Wieland Voigt, Karin Jordan, Hans-Joachim Schmoll
US Oncological Review, 2009;5(1):32-5
Targeted Chemotherapy
Targeted Therapy in Combination with Chemotherapy in Recurrent and/or Metastatic Head and Neck Cancer
Pol Specenier, Jan B Vermorken
European Oncology, 2010;6(1):43-6
Medullary or Anaplastic Thyroid Cancer
Advances in the Prognosis and Treatment of Medullary or Anaplastic Thyroid Cancer
Wieland Voigt, Karin Jordan, Hans-Joachim Schmoll
US Oncological Review, 2009;5(1):32-5
Editor's choice
Also in Editor's Choice











